Point 1 needs further exploration with respect to the arousal dimension, and point 2 would benefit from future studies exploring relevant specific emotional contents.
Thus, improving women's use of contraceptives will benefit from future studies that explore reasons why men's awareness of, and support for, contraception may not translate to actual contraceptive use by their spouses.
This field of research would benefit from future studies that evaluate the efficacy of these programs compared to standard care and assess patient-important outcomes that can be incorporated into a personalized treatment approach.
This area of research would benefit from future studies that utilize more detailed and precise information on dietary intake, alternative study designs (such as interventions) and other genetic regions that do not reach genome-wide statistical significance in main effects GWAS.
Linking genomic structural variation to phenotypic differences and physiological performance remains a major challenge, and so answering the question of whether and how artificial selection may have affected CNVR evolution during the domestication of cattle will greatly benefit from future studies trying to link CNV to individual's development, physiology, behavior, and morphology.
are influenced by management and would benefit from future experimental study.
It is therefore plausible that (some) people honestly signal their potential or intended contribution to care [ 34, 55], but this would benefit from future empirical study.
The field would benefit from future research studies that examine the similarities and differences between the demands placed on facilitators of adaptive and specified PD programs and ensuring they are prepared to meet those demands.
Clinical prediction rules are necessary to determine who will most benefit from future interventional studies designed to reduce the frequency and severity of PCS versus the current standard treatment of rest.
However, the limitation to this study is that we were unable to verify which class of inhibitor such patient would potentially receive optimal therapeutic benefit from; while future studies aim to identify co-expressing PDGCX models to enable preclinical testing.
